416 related articles for article (PubMed ID: 27911310)
21. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M
Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600
[TBL] [Abstract][Full Text] [Related]
22. Two cholinesterase inhibitors trigger dissimilar effects on behavior and body weight in C57BL/6 mice: The case of chlorpyrifos and rivastigmine.
Basaure P; Peris-Sampedro F; Cabré M; Reverte I; Colomina MT
Behav Brain Res; 2017 Feb; 318():1-11. PubMed ID: 27732893
[TBL] [Abstract][Full Text] [Related]
23. Long-lasting impairment in hippocampal neurogenesis associated with amyloid deposition in a knock-in mouse model of familial Alzheimer's disease.
Zhang C; McNeil E; Dressler L; Siman R
Exp Neurol; 2007 Mar; 204(1):77-87. PubMed ID: 17070803
[TBL] [Abstract][Full Text] [Related]
24. Melatonin Attenuates Memory Impairment, Amyloid-β Accumulation, and Neurodegeneration in a Rat Model of Sporadic Alzheimer's Disease.
Rudnitskaya EA; Muraleva NA; Maksimova KY; Kiseleva E; Kolosova NG; Stefanova NA
J Alzheimers Dis; 2015; 47(1):103-16. PubMed ID: 26402759
[TBL] [Abstract][Full Text] [Related]
25. proBDNF Accelerates Brain Amyloid-β Deposition and Learning and Memory Impairment in APPswePS1dE9 Transgenic Mice.
Chen J; Zhang T; Jiao S; Zhou X; Zhong J; Wang Y; Liu J; Deng J; Wang S; Xu Z
J Alzheimers Dis; 2017; 59(3):941-949. PubMed ID: 28697556
[TBL] [Abstract][Full Text] [Related]
26. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF
Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer's disease mice.
Alves S; Churlaud G; Audrain M; Michaelsen-Preusse K; Fol R; Souchet B; Braudeau J; Korte M; Klatzmann D; Cartier N
Brain; 2017 Mar; 140(3):826-842. PubMed ID: 28003243
[TBL] [Abstract][Full Text] [Related]
28. Hippocampal neurogenesis in the APP/PS1/nestin-GFP triple transgenic mouse model of Alzheimer's disease.
Zeng Q; Zheng M; Zhang T; He G
Neuroscience; 2016 Feb; 314():64-74. PubMed ID: 26639620
[TBL] [Abstract][Full Text] [Related]
29. Impaired hippocampal neurogenesis and its enhancement with ghrelin in 5XFAD mice.
Moon M; Cha MY; Mook-Jung I
J Alzheimers Dis; 2014; 41(1):233-41. PubMed ID: 24583405
[TBL] [Abstract][Full Text] [Related]
30. Onset of hippocampus-dependent memory impairments in 5XFAD transgenic mouse model of Alzheimer's disease.
Girard SD; Jacquet M; Baranger K; Migliorati M; Escoffier G; Bernard A; Khrestchatisky M; Féron F; Rivera S; Roman FS; Marchetti E
Hippocampus; 2014 Jul; 24(7):762-72. PubMed ID: 24596271
[TBL] [Abstract][Full Text] [Related]
31. Serotonin 5-HT6 receptors affect cognition in a mouse model of Alzheimer's disease by regulating cilia function.
Hu L; Wang B; Zhang Y
Alzheimers Res Ther; 2017 Sep; 9(1):76. PubMed ID: 28931427
[TBL] [Abstract][Full Text] [Related]
32. Rutin improves spatial memory in Alzheimer's disease transgenic mice by reducing Aβ oligomer level and attenuating oxidative stress and neuroinflammation.
Xu PX; Wang SW; Yu XL; Su YJ; Wang T; Zhou WW; Zhang H; Wang YJ; Liu RT
Behav Brain Res; 2014 May; 264():173-80. PubMed ID: 24512768
[TBL] [Abstract][Full Text] [Related]
33. Effects of gintonin-enriched fraction on hippocampal cell proliferation in wild-type mice and an APPswe/PSEN-1 double Tg mouse model of Alzheimer's disease.
Kim HJ; Kim DJ; Shin EJ; Lee BH; Choi SH; Hwang SH; Rhim H; Cho IH; Kim HC; Nah SY
Neurochem Int; 2016 Dec; 101():56-65. PubMed ID: 27765516
[TBL] [Abstract][Full Text] [Related]
34. Chronic treatment with the α2-adrenoceptor antagonist fluparoxan prevents age-related deficits in spatial working memory in APP×PS1 transgenic mice without altering β-amyloid plaque load or astrocytosis.
Scullion GA; Kendall DA; Marsden CA; Sunter D; Pardon MC
Neuropharmacology; 2011; 60(2-3):223-34. PubMed ID: 20850464
[TBL] [Abstract][Full Text] [Related]
35. O-linked β-N-acetylglucosaminidase inhibitor attenuates β-amyloid plaque and rescues memory impairment.
Kim C; Nam DW; Park SY; Song H; Hong HS; Boo JH; Jung ES; Kim Y; Baek JY; Kim KS; Cho JW; Mook-Jung I
Neurobiol Aging; 2013 Jan; 34(1):275-85. PubMed ID: 22503002
[TBL] [Abstract][Full Text] [Related]
36. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
[TBL] [Abstract][Full Text] [Related]
37. Standardized Herbal Formula PM012 Decreases Cognitive Impairment and Promotes Neurogenesis in the 3xTg AD Mouse Model of Alzheimer's Disease.
Ye M; Chung HS; An YH; Lim SJ; Choi W; Yu AR; Kim JS; Kang M; Cho S; Shim I; Bae H
Mol Neurobiol; 2016 Oct; 53(8):5401-12. PubMed ID: 26446019
[TBL] [Abstract][Full Text] [Related]
38. Amyloid-beta causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons.
Chiba T; Yamada M; Sasabe J; Terashita K; Shimoda M; Matsuoka M; Aiso S
Mol Psychiatry; 2009 Feb; 14(2):206-22. PubMed ID: 18813209
[TBL] [Abstract][Full Text] [Related]
39. Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease.
Guo C; Wang T; Zheng W; Shan ZY; Teng WP; Wang ZY
Neurobiol Aging; 2013 Feb; 34(2):562-75. PubMed ID: 22717236
[TBL] [Abstract][Full Text] [Related]
40. Vitamin D Improves Neurogenesis and Cognition in a Mouse Model of Alzheimer's Disease.
Morello M; Landel V; Lacassagne E; Baranger K; Annweiler C; Féron F; Millet P
Mol Neurobiol; 2018 Aug; 55(8):6463-6479. PubMed ID: 29318446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
